Comprehensive Allergy Immunotherapy Solutions from GREER®
Get in touch with your GREER® Allergy Sales Consultant, Customer Care Specialist, or Medical & Scientific Affairs team for answers to your allergy immunotherapy questions.
GREER offers a broad selection of high-quality extracts for testing and treatment, sterile diluents, sterile empty vials, and single- and multiple-site skin testing devices.
The GREER allergy immunotherapy treatment options include GREER® Extracts™ and ORALAIR® (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) tablet for sublingual use.
ORALAIR is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for any of the 5 grass species contained in this product. ORALAIR is approved for use in persons 10 through 65 years of age.
ORALAIR is not indicated for the immediate relief of allergy symptoms.
Initiate treatment with ORALAIR 4 months before the expected onset of each grass pollen season and maintain it throughout the grass pollen season.1
CLICK HERE to visit ORALAIR.com to learn more about the first and only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses.
Please see Important Safety Information, including Boxed Warning, below and click here for full Prescribing Information and Medication Guide.
Allergenic extracts are indicated for skin test diagnosis and treatment (immunotherapy) of patients with seasonal and perennial allergies.
Please see Important Safety Information, including Boxed Warning, below and click here for Package Inserts.
- ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) full prescribing information. Stallergenes S.A. 2014.